Plant-Based Diet Linked to Lower Risk of Prostate Cancer Progression: JAMA
Researchers have found that a higher intake of plant foods after a prostate cancer diagnosis is associated with a lower risk of cancer progression. The findings from a recent longitudinal observational cohort study involving 2,062 men with nonmetastatic prostate cancer suggest that postdiagnostic plant-based diet patterns can have a significant impact on reducing the risk of prostate cancer progression. This study was published in the journal JAMA Network Open by Vivian N. and colleagues.
Plant-based diets have been linked to numerous health and environmental benefits, including the prevention of various cancers. However, the impact of a plant-based diet on individuals already diagnosed with prostate cancer is less understood. This study aims to examine the association between postdiagnostic plant-based dietary patterns and the risk of prostate cancer progression and prostate cancer-specific mortality.
The study analyzed data from men with biopsy-proven nonmetastatic prostate cancer enrolled in the Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE) between 1999 and 2018. Participants completed a comprehensive diet and lifestyle questionnaire, including a validated food frequency questionnaire (FFQ), between 2004 and 2016. Overall plant-based diet index (PDI) and healthful plant-based diet index (hPDI) scores were calculated from the FFQ.
The key findings of the study were:
• The study included 2,062 men with a median age of 65.0 years. Most participants identified as White (95%), followed by African American (3%), Asian or Pacific Islander (<1%), Latino (1%), and American Indian or Alaska Native (<1%).
• The median time from prostate cancer diagnosis to the completion of the FFQ was 31.3 months.
• The median follow-up after the FFQ was 6.5 years, during which 190 progression events and 61 prostate cancer-specific mortality events were observed.
• Men in the highest quintile of PDI had a 47% lower risk of cancer progression compared to those in the lowest quintile (HR 0.53; 95% CI 0.37-0.74; P for trend = .003).
• While the overall hPDI was not associated with a significant risk reduction, among 680 individuals with Gleason grade 7 or higher at diagnosis, the highest hPDI quintile was associated with a 55% lower risk of progression compared to the lowest quintile (HR 0.45; 95% CI 0.25-0.81; P for trend = .01).
The study's findings suggest that a plant-based diet may be beneficial for men with prostate cancer, particularly for those with higher Gleason grades. Higher intake of plant-based foods after a prostate cancer diagnosis could help reduce the risk of cancer progression. The results support the potential role of nutritional assessment and counseling for patients with prostate cancer to establish healthy dietary practices.
Higher intake of plant foods following a prostate cancer diagnosis was associated with a lower risk of cancer progression. Nutritional assessment and counseling may be recommended for prostate cancer patients to support overall health and well-being.
Reference:
Liu, V. N., Van Blarigan, E. L., Zhang, L., Graff, R. E., Loeb, S., Langlais, C. S., Cowan, J. E., Carroll, P. R., Chan, J. M., & Kenfield, S. A. (2024). Plant-based diets and disease progression in men with prostate cancer. JAMA Network Open, 7(5), e249053. https://doi.org/10.1001/jamanetworkopen.2024.9053
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.